Global Covid-19 Treatment Medicine Market Research Report 2022
SKU ID :QYR-20833462 | Published Date: 04-May-2022 | No. of pages: 94Description
TOC
1 Covid-19 Treatment Medicine Market Overview
1.1 Product Overview and Scope of Covid-19 Treatment Medicine
1.2 Covid-19 Treatment Medicine Segment by Type
1.2.1 Global Covid-19 Treatment Medicine Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral
1.2.3 Injetion
1.3 Covid-19 Treatment Medicine Segment by Application
1.3.1 Global Covid-19 Treatment Medicine Sales Comparison by Application: (2022-2028)
1.3.2 Mild-to-Moderate COVID-19
1.3.3 Severe Patient
1.4 Global Covid-19 Treatment Medicine Market Size Estimates and Forecasts
1.4.1 Global Covid-19 Treatment Medicine Revenue 2017-2028
1.4.2 Global Covid-19 Treatment Medicine Sales 2017-2028
1.4.3 Covid-19 Treatment Medicine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Covid-19 Treatment Medicine Market Competition by Manufacturers
2.1 Global Covid-19 Treatment Medicine Sales Market Share by Manufacturers (2017-2022)
2.2 Global Covid-19 Treatment Medicine Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Covid-19 Treatment Medicine Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Covid-19 Treatment Medicine Manufacturing Sites, Area Served, Product Type
2.5 Covid-19 Treatment Medicine Market Competitive Situation and Trends
2.5.1 Covid-19 Treatment Medicine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Covid-19 Treatment Medicine Players Market Share by Revenue
2.5.3 Global Covid-19 Treatment Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Covid-19 Treatment Medicine Retrospective Market Scenario by Region
3.1 Global Covid-19 Treatment Medicine Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Covid-19 Treatment Medicine Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Covid-19 Treatment Medicine Market Facts & Figures by Country
3.3.1 North America Covid-19 Treatment Medicine Sales by Country
3.3.2 North America Covid-19 Treatment Medicine Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Covid-19 Treatment Medicine Market Facts & Figures by Country
3.4.1 Europe Covid-19 Treatment Medicine Sales by Country
3.4.2 Europe Covid-19 Treatment Medicine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Covid-19 Treatment Medicine Market Facts & Figures by Region
3.5.1 Asia Pacific Covid-19 Treatment Medicine Sales by Region
3.5.2 Asia Pacific Covid-19 Treatment Medicine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Covid-19 Treatment Medicine Market Facts & Figures by Country
3.6.1 Latin America Covid-19 Treatment Medicine Sales by Country
3.6.2 Latin America Covid-19 Treatment Medicine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Covid-19 Treatment Medicine Market Facts & Figures by Country
3.7.1 Middle East and Africa Covid-19 Treatment Medicine Sales by Country
3.7.2 Middle East and Africa Covid-19 Treatment Medicine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Covid-19 Treatment Medicine Historic Market Analysis by Type
4.1 Global Covid-19 Treatment Medicine Sales Market Share by Type (2017-2022)
4.2 Global Covid-19 Treatment Medicine Revenue Market Share by Type (2017-2022)
4.3 Global Covid-19 Treatment Medicine Price by Type (2017-2022)
5 Global Covid-19 Treatment Medicine Historic Market Analysis by Application
5.1 Global Covid-19 Treatment Medicine Sales Market Share by Application (2017-2022)
5.2 Global Covid-19 Treatment Medicine Revenue Market Share by Application (2017-2022)
5.3 Global Covid-19 Treatment Medicine Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Pfizer (Paxlovid)
6.1.1 Pfizer (Paxlovid) Corporation Information
6.1.2 Pfizer (Paxlovid) Description and Business Overview
6.1.3 Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Pfizer (Paxlovid) Covid-19 Treatment Medicine Product Portfolio
6.1.5 Pfizer (Paxlovid) Recent Developments/Updates
6.2 VEKLURY (Remdesivir)
6.2.1 VEKLURY (Remdesivir) Corporation Information
6.2.2 VEKLURY (Remdesivir) Description and Business Overview
6.2.3 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2017-2022)
6.2.4 VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product Portfolio
6.2.5 VEKLURY (Remdesivir) Recent Developments/Updates
6.3 Lagevrio
6.3.1 Lagevrio Corporation Information
6.3.2 Lagevrio Description and Business Overview
6.3.3 Lagevrio Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Lagevrio Covid-19 Treatment Medicine Product Portfolio
6.3.5 Lagevrio Recent Developments/Updates
6.4 GSK (Sotrovimab)
6.4.1 GSK (Sotrovimab) Corporation Information
6.4.2 GSK (Sotrovimab) Description and Business Overview
6.4.3 GSK (Sotrovimab) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GSK (Sotrovimab) Covid-19 Treatment Medicine Product Portfolio
6.4.5 GSK (Sotrovimab) Recent Developments/Updates
6.5 Regeneron (Ronapreve)
6.5.1 Regeneron (Ronapreve) Corporation Information
6.5.2 Regeneron (Ronapreve) Description and Business Overview
6.5.3 Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Regeneron (Ronapreve) Covid-19 Treatment Medicine Product Portfolio
6.5.5 Regeneron (Ronapreve) Recent Developments/Updates
6.6 Yiling Pharmaceutical
6.6.1 Yiling Pharmaceutical Corporation Information
6.6.2 Yiling Pharmaceutical Description and Business Overview
6.6.3 Yiling Pharmaceutical Covid-19 Treatment Medicine Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Yiling Pharmaceutical Covid-19 Treatment Medicine Product Portfolio
6.6.5 Yiling Pharmaceutical Recent Developments/Updates
7 Covid-19 Treatment Medicine Manufacturing Cost Analysis
7.1 Covid-19 Treatment Medicine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Covid-19 Treatment Medicine
7.4 Covid-19 Treatment Medicine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Covid-19 Treatment Medicine Distributors List
8.3 Covid-19 Treatment Medicine Customers
9 Covid-19 Treatment Medicine Market Dynamics
9.1 Covid-19 Treatment Medicine Industry Trends
9.2 Covid-19 Treatment Medicine Market Drivers
9.3 Covid-19 Treatment Medicine Market Challenges
9.4 Covid-19 Treatment Medicine Market Restraints
10 Global Market Forecast
10.1 Covid-19 Treatment Medicine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Covid-19 Treatment Medicine by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Covid-19 Treatment Medicine by Type (2023-2028)
10.2 Covid-19 Treatment Medicine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Covid-19 Treatment Medicine by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Covid-19 Treatment Medicine by Application (2023-2028)
10.3 Covid-19 Treatment Medicine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Covid-19 Treatment Medicine by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Covid-19 Treatment Medicine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Tables & Figures
List of Tables
Table 1. Global Covid-19 Treatment Medicine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Covid-19 Treatment Medicine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Covid-19 Treatment Medicine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Covid-19 Treatment Medicine Market Competitive Situation by Manufacturers in 2021
Table 5. Global Covid-19 Treatment Medicine Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Covid-19 Treatment Medicine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Covid-19 Treatment Medicine Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Covid-19 Treatment Medicine Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Covid-19 Treatment Medicine Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Covid-19 Treatment Medicine Manufacturing Sites and Area Served
Table 11. Manufacturers Covid-19 Treatment Medicine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Covid-19 Treatment Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Covid-19 Treatment Medicine as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Covid-19 Treatment Medicine Sales by Region (2017-2022) & (K Units)
Table 16. Global Covid-19 Treatment Medicine Sales Market Share by Region (2017-2022)
Table 17. Global Covid-19 Treatment Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Covid-19 Treatment Medicine Revenue Market Share by Region (2017-2022)
Table 19. North America Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 20. North America Covid-19 Treatment Medicine Sales Market Share by Country (2017-2022)
Table 21. North America Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Covid-19 Treatment Medicine Revenue Market Share by Country (2017-2022)
Table 23. Europe Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 24. Europe Covid-19 Treatment Medicine Sales Market Share by Country (2017-2022)
Table 25. Europe Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Covid-19 Treatment Medicine Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Covid-19 Treatment Medicine Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Covid-19 Treatment Medicine Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Covid-19 Treatment Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Covid-19 Treatment Medicine Revenue Market Share by Region (2017-2022)
Table 31. Latin America Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Covid-19 Treatment Medicine Sales Market Share by Country (2017-2022)
Table 33. Latin America Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Covid-19 Treatment Medicine Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Covid-19 Treatment Medicine Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Covid-19 Treatment Medicine Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Covid-19 Treatment Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Covid-19 Treatment Medicine Revenue Market Share by Country (2017-2022)
Table 39. Global Covid-19 Treatment Medicine Sales by Type (2017-2022) & (K Units)
Table 40. Global Covid-19 Treatment Medicine Sales Market Share by Type (2017-2022)
Table 41. Global Covid-19 Treatment Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Covid-19 Treatment Medicine Revenue Share by Type (2017-2022)
Table 43. Global Covid-19 Treatment Medicine Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Covid-19 Treatment Medicine Sales (K Units) by Application (2017-2022)
Table 45. Global Covid-19 Treatment Medicine Sales Market Share by Application (2017-2022)
Table 46. Global Covid-19 Treatment Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Covid-19 Treatment Medicine Revenue Share by Application (2017-2022)
Table 48. Global Covid-19 Treatment Medicine Price by Application (2017-2022) & (US$/Unit)
Table 49. Pfizer (Paxlovid) Corporation Information
Table 50. Pfizer (Paxlovid) Description and Business Overview
Table 51. Pfizer (Paxlovid) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Pfizer (Paxlovid) Covid-19 Treatment Medicine Product
Table 53. Pfizer (Paxlovid) Recent Developments/Updates
Table 54. VEKLURY (Remdesivir) Corporation Information
Table 55. VEKLURY (Remdesivir) Description and Business Overview
Table 56. VEKLURY (Remdesivir) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. VEKLURY (Remdesivir) Covid-19 Treatment Medicine Product
Table 58. VEKLURY (Remdesivir) Recent Developments/Updates
Table 59. Lagevrio Corporation Information
Table 60. Lagevrio Description and Business Overview
Table 61. Lagevrio Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Lagevrio Covid-19 Treatment Medicine Product
Table 63. Lagevrio Recent Developments/Updates
Table 64. GSK (Sotrovimab) Corporation Information
Table 65. GSK (Sotrovimab) Description and Business Overview
Table 66. GSK (Sotrovimab) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. GSK (Sotrovimab) Covid-19 Treatment Medicine Product
Table 68. GSK (Sotrovimab) Recent Developments/Updates
Table 69. Regeneron (Ronapreve) Corporation Information
Table 70. Regeneron (Ronapreve) Description and Business Overview
Table 71. Regeneron (Ronapreve) Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Regeneron (Ronapreve) Covid-19 Treatment Medicine Product
Table 73. Regeneron (Ronapreve) Recent Developments/Updates
Table 74. Yiling Pharmaceutical Corporation Information
Table 75. Yiling Pharmaceutical Description and Business Overview
Table 76. Yiling Pharmaceutical Covid-19 Treatment Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Yiling Pharmaceutical Covid-19 Treatment Medicine Product
Table 78. Yiling Pharmaceutical Recent Developments/Updates
Table 79. Production Base and Market Concentration Rate of Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Covid-19 Treatment Medicine Distributors List
Table 82. Covid-19 Treatment Medicine Customers List
Table 83. Covid-19 Treatment Medicine Market Trends
Table 84. Covid-19 Treatment Medicine Market Drivers
Table 85. Covid-19 Treatment Medicine Market Challenges
Table 86. Covid-19 Treatment Medicine Market Restraints
Table 87. Global Covid-19 Treatment Medicine Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Covid-19 Treatment Medicine Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Covid-19 Treatment Medicine Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 90. Global Covid-19 Treatment Medicine Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Covid-19 Treatment Medicine Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Covid-19 Treatment Medicine Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Covid-19 Treatment Medicine Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 94. Global Covid-19 Treatment Medicine Revenue Market Share Forecast by Application (2023-2028)
Table 95. Global Covid-19 Treatment Medicine Sales Forecast by Region (2023-2028) & (K Units)
Table 96. Global Covid-19 Treatment Medicine Sales Market Share Forecast by Region (2023-2028)
Table 97. Global Covid-19 Treatment Medicine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 98. Global Covid-19 Treatment Medicine Revenue Market Share Forecast by Region (2023-2028)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Covid-19 Treatment Medicine
Figure 2. Global Covid-19 Treatment Medicine Market Share by Type in 2021 & 2028
Figure 3. Oral Product Picture
Figure 4. Injetion Product Picture
Figure 5. Global Covid-19 Treatment Medicine Market Share by Application in 2021 & 2028
Figure 6. Mild-to-Moderate COVID-19
Figure 7. Severe Patient
Figure 8. Global Covid-19 Treatment Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Covid-19 Treatment Medicine Market Size (2017-2028) & (US$ Million)
Figure 10. Global Covid-19 Treatment Medicine Sales (2017-2028) & (K Units)
Figure 11. Covid-19 Treatment Medicine Sales Share by Manufacturers in 2021
Figure 12. Global Covid-19 Treatment Medicine Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Covid-19 Treatment Medicine Players: Market Share by Revenue in 2021
Figure 14. Covid-19 Treatment Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Covid-19 Treatment Medicine Sales Market Share by Region (2017-2022)
Figure 16. Global Covid-19 Treatment Medicine Sales Market Share by Region in 2021
Figure 17. Global Covid-19 Treatment Medicine Revenue Market Share by Region (2017-2022)
Figure 18. Global Covid-19 Treatment Medicine Revenue Market Share by Region in 2021
Figure 19. United States Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Colombia Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Covid-19 Treatment Medicine Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Covid-19 Treatment Medicine by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Covid-19 Treatment Medicine
Figure 44. Manufacturing Process Analysis of Covid-19 Treatment Medicine
Figure 45. Covid-19 Treatment Medicine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Companies
Pfizer (Paxlovid)
VEKLURY (Remdesivir)
Lagevrio
GSK (Sotrovimab)
Regeneron (Ronapreve)
Yiling Pharmaceutical
- PRICE
-
$2900$5800$4350Buy Now